Viewing nowCiprobay 250mg (Ciprofloxacin Hydrochloride Hydrate)
Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Bayer Korea Co., Ltd.

MFDS item code 201905731 · Approved 2019.08.14 · Insurance code 641106100
Effective for the treatment of respiratory infections and urinary tract infections
This medication is used to treat infections caused by various bacteria. It is effective against respiratory infections except for acute bronchitis and community-acquired pneumonia. It is also used for infections of the ear, nose, and throat, as well as bacterial prostatitis, acute cystitis, and pyelonephritis, among other urinary infections. It is suitable for treating infections in various other areas such as gastrointestinal and biliary tract infections, skin and soft tissue infections, and bone and joint infections. Additionally, it is applicable for gonococcal cervicitis and urethritis, gynecological infections, peritonitis, and paraurethral gland infections. However, since it is a fluoroquinolone antibiotic, it should be used cautiously for some mild infections (such as acute non-sinusitis and chronic bronchitis) only when no other treatment options exist.
In general, adults take ciprofloxacin at a dose of 250 to 500 mg orally, twice daily between meals. In the case of severe complicated infections, the dose may be increased to 750 mg, twice daily. For acute infections, treatment usually lasts 5 to 10 days, and administration should continue for at least 3 days after symptoms have resolved. In patients with renal impairment, the dosage should be adjusted according to creatinine clearance.
This medication can cause serious side effects such as tendonitis or tendon rupture, peripheral neuropathy, and central nervous system effects, so caution is needed. In particular, patients with myasthenia gravis may experience exacerbation of symptoms and should not use this medication. This medication is used to treat certain bacterial infections and is recommended to be administered only when no other treatment options are available. Elderly patients, those with reduced kidney function, and patients receiving certain immunosuppressive therapies may be at higher risk for tendon rupture when taking this medication; therefore, caution is advised. Co-administration with corticosteroids should be avoided, and if tendon pain or inflammation occurs, administration should be stopped immediately and rest taken. This medication has neuromuscular blocking effects, which can worsen symptoms of myasthenia gravis, so it should be used cautiously in these patients. Those with an allergy to this medication, pregnant or breastfeeding women, children under 18 years of age, and patients with epilepsy should not be administered this medication. Patients with a history of seizures, severe renal impairment, elderly patients, and those with central nervous system diseases should use this medication cautiously. This medication can cause various side effects, and if symptoms such as rash, difficulty breathing, psychiatric symptoms, visual disturbances, muscle pain, or renal abnormalities occur, immediate consultation with a physician is necessary. Additionally, this medication has many drug interactions, so caution is needed depending on other medications being taken, especially with blood glucose-regulating drugs, anticoagulants, and CNS drugs. It is not recommended during pregnancy or breastfeeding, and if breastfeeding, either discontinuation of breastfeeding or avoidance of administration is necessary. Safety has not been established in children and adolescents in growth; therefore, it is not to be used in this population. Elderly patients may have increased drug concentrations due to reduced kidney function; hence, dosage and dosing intervals should be adjusted cautiously. In cases of overdose, renal toxicity may occur, requiring appropriate treatment along with measures to reduce drug absorption during emergencies. This medication should be stored away from direct sunlight and ultraviolet light, and out of reach of children.
Tendonitis, tendon rupture, peripheral neuropathy, central nervous system effects, exacerbation of myasthenia gravis, anaphylaxis, anaphylactic shock, serum sickness-like reactions, (life-threatening) bone marrow suppression, liver dysfunction, jaundice, cholestatic jaundice, liver necrosis, severe allergic reactions, severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis), seizures, convulsions, status epilepticus, coma, severe hypoglycemia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container that is impervious to air, at a temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the drug's efficacy and prevent deterioration.
White to light yellow round film-coated tablets
10 tablets/box, 100 tablets/box [(10 tablets/PPT*10)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCiprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Bayer Korea Co., Ltd.

Ciprofloxacin Hydrochloride 291.5mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Ciprofloxacin Hydrochloride
Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride 291mg
Tablet · Prescription medication
Il Dong Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride 582mg
Tablet · Prescription medication
Il Dong Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Korea United Pharm, Inc.
Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
SK Chemicals Co., Ltd.

Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.